Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimens for use with PCSK9 inhibitors

Dosing regimens for use with PCSK9 inhibitors

US Patent 10428157 · Granted Oct 1, 2019

Estimated economic value: $39,621,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human antibodies to PCSK9 for use in methods of treating particular groups of su2024
Human antibodies to PCSK9 for use in methods of treating particular groups of su2024
Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibi2024
Methods for reducing or eliminating the need for lipoprotein apheresis in patien2024
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Human antibodies to PCSK9 for use in methods of treating particular groups of su2022
Human antibodies to PCSK9 for use in methods of treating particular groups of su2022
Methods for altering body composition by administering a GDF8 inhibitor and an A2022